Cardiology
HeartBeam Inc.'s FDA-Cleared System Revolutionizes Cardiac Care with Portable Technology
HeartBeam Inc.'s innovative, FDA-cleared portable ECG system marks a significant advancement in cardiac care by enabling arrhythmia monitoring outside traditional clinical settings.
NeuralBase AI Ltd. Advances HeartEase App Development for Android and iOS
NeuralBase AI Ltd. announces the completion of the Android version of its HeartEase app, marking a significant step towards its market release and the upcoming iOS version testing.
Dr. Rachel Fischer Joins Boone Heart & Wellness to Enhance Preventive Medicine Services
Dr. Rachel Fischer's addition to Boone Heart & Wellness underscores the growing importance of preventive medicine in addressing chronic conditions and optimizing patient health.
Study Links Heart Scar Tissue to Dangerous Rhythms in Older Male Athletes
A U.K. study finds scar tissue in the heart may increase the risk of dangerous heart rhythms in healthy, long-time male endurance athletes over 50, highlighting the importance of monitoring and safety measures in sports.
Emerald Coast Heart & AFib Expands to Fort Walton Beach, Enhancing Cardiac Rhythm Care Access
Emerald Coast Heart & AFib's expansion into Fort Walton Beach marks a significant advancement in specialized cardiac rhythm care for Northwest Florida, offering cutting-edge treatments and patient education under Dr. Ian Weisberg's leadership.
HeartBeam Inc. (NASDAQ: BEAT) Pioneers At-Home Cardiac Care with Innovative ECG Technology
HeartBeam Inc. is revolutionizing cardiac care with its at-home detection and monitoring technology, offering a potential shift in how cardiac conditions are managed outside traditional medical settings.
HeartBeam Inc. Receives FDA Clearance for Innovative Cable-Free ECG System
HeartBeam Inc. has achieved FDA 510(k) clearance for its pioneering, credit card-sized, cable-free ECG system, enhancing remote arrhythmia detection and cardiac care accessibility.
HeartBeam Inc. Pioneers Cable-Free ECG System for At-Home Cardiac Monitoring
HeartBeam Inc. introduces a revolutionary cable-free system for synthesizing 12-lead ECGs from 3D signals, enabling patients to record their symptoms anywhere, potentially transforming cardiac care by facilitating early detection and timely intervention.
HeartBeam Inc.'s VALID-ECG Study Confirms High Diagnostic Accuracy of Synthesized 12-Lead ECG
HeartBeam Inc.'s innovative credit card-sized ECG device has shown a 93.4% diagnostic agreement with standard ECGs in the VALID-ECG study, marking a significant step towards portable cardiac care solutions.
HeartBeam Inc. Advances Toward Commercialization with Promising Q1 2025 Results
HeartBeam Inc. reports significant progress in its Q1 2025 results, including successful clinical endpoints in its VALID-ECG study and strategic collaborations, marking a pivotal step towards the commercialization of its innovative cardiac care technology.
American Heart Association Certifies First Comprehensive Chest Pain Centers in India and Mexico
The American Heart Association has certified the first Comprehensive Chest Pain Centers in India and Mexico, marking a significant advancement in global cardiac care and addressing the leading cause of death worldwide.
New Study Validates PREVENT Risk Calculator for Heart Attack Prediction
A study of nearly 7,000 adults demonstrates the accuracy of the American Heart Association's PREVENT risk calculator in identifying individuals with potential heart disease risk, using coronary calcium scores as a complementary screening tool.
Sedentary Behavior Linked to Higher Cardiac Event Risk After Hospitalization
A new study reveals that prolonged sedentary time increases the risk of subsequent cardiac events within a year after hospitalization. Replacing sitting time with light physical activity or sleep can significantly reduce cardiovascular risks.
HeartBeam Advances Cardiac Care Technology with FDA Milestone and Strategic Partnerships
Medical technology company HeartBeam achieved significant progress in Q1 2025, completing a pivotal study for its 12-lead ECG synthesis software and expanding strategic partnerships while raising crucial funding for commercialization.
New Study Reveals High Mortality Rates in Broken Heart Syndrome
A comprehensive national study tracked Takotsubo cardiomyopathy rates from 2016 to 2020, revealing persistently high death and complication rates across different demographic groups. The research highlights significant gender and age-related variations in this stress-induced heart condition.
HeartBeam Expands Board with CEO Robert Eno's Appointment
HeartBeam Inc. strengthens its leadership by appointing CEO Robert Eno to its Board of Directors, signaling strategic preparation for the commercial launch of its innovative 3D ECG technology.
HeartBeam Advances Portable 12-Lead ECG Technology with Promising Clinical Study Results
Medical technology company HeartBeam demonstrates high diagnostic accuracy for its innovative credit card-sized ECG device, potentially revolutionizing remote cardiac monitoring and patient care.
HeartBeam and AccurKardia Partner to Advance Remote ECG Monitoring Technology
Medical technology firm HeartBeam collaborates with AccurKardia to integrate advanced ECG analysis software into a cable-free 12-lead ECG device, potentially transforming remote cardiac care and diagnosis.
AI-Powered ECG Analysis Shows Promise in Detecting Cognitive Decline
A new study reveals that artificial intelligence analysis of ECG data could potentially identify premature aging and cognitive decline, offering a novel approach to early detection of age-related cognitive issues using widely available medical technology.